Physician profile
Dali Fan
NPI 1245289545
$48,505.11
in general payments reported to CMS, 2019-2025
27 companies · $9,799 in 2025
The $9,799 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,193 · 2020: $14K · 2021: $2,085 · 2022: $7,419 · 2023: $3,532 · 2024: $2,923 · 2025: $9,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,307 · Food and Beverage: $4,939 · Travel and Lodging: $3,008 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,307.00 |
| Food and Beverage | $4,938.78 |
| Travel and Lodging | $3,007.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,517.34 | 2019-2025 | Aveir, Ensite, Dragonfly Opstar |
| Biotronik INC. | $5,916.14 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Sanofi-Aventis U.S. LLC | $5,330.46 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $4,607.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $2,961.91 | 2021-2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| E.R. Squibb & Sons, L.L.C. | $805.55 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $763.22 | 2019-2025 | Lifevest |
| Pfizer INC. | $466.13 | 2019-2022 | |
| Shockwave Medical, INC | $453.46 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $316.85 | 2021-2023 | Impella |
| Janssen Pharmaceuticals, INC | $307.54 | 2019-2020 | |
| Amgen INC. | $301.53 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $291.44 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Linq II |
| Boston Scientific Corporation | $200.07 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $175.44 | 2024 | Assure Wcd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $162.96 | 2025 | Gore Cardioform Septal Occluder |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $124.63 | 2025 | Winrevair |
| Kiniksa Pharmaceuticals, LTD. | $122.31 | 2023 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $120.32 | 2019 | |
| Chiesi USA, INC. | $112.00 | 2025 | Kengreal |
| Cordis US Corp. | $105.36 | 2025 | Mynx Control Venous, Infiniti |
| Beigene USA, INC. | $102.32 | 2023 | Brukinsa |
| Edwards Lifesciences Corporation | $33.08 | 2020 | |
| Intuitive Surgical, INC. | $27.00 | 2022 | |
| Ekos Corporation | $19.22 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dali Fan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.